Laddar...
Certolizumab pegol – Tumor necrosis factor inhibitor for refractory uveitis
PURPOSE: The purpose of our study is to report our experience with the use of certolizumab pegol in patients with refractory non-infectious uveitis. OBSERVATIONS: We present a case series of three patients with non-infectious uveitis, treated with twice-monthly subcutaneous certolizumab pegol. All o...
Sparad:
| I publikationen: | Am J Ophthalmol Case Rep |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Elsevier
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7068621/ https://ncbi.nlm.nih.gov/pubmed/32190782 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajoc.2020.100633 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|